VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GDRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GDRXGoodRx Holdings, Inc.
$2.80$971M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGDRXQuarterly Financials

GoodRx Holdings, Inc. (GDRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

GoodRx Holdings, Inc. (GDRX) quarterly income statement — complete revenue, gross profit & net income history

GDRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue194.01M194.78M196.03M203.07M202.97M198.58M195.25M200.61M197.88M196.64M179.96M189.68M
Revenue Growth %-4.42%-1.91%0.4%1.23%2.57%0.99%8.5%5.76%7.55%6.81%-3.93%-1.11%
Cost of Goods Sold20.16M17.46M13.42M33.08M13.36M12.19M11.68M11.87M12.47M15.17M18.72M16.34M
COGS % of Revenue10.39%8.97%6.85%16.29%6.58%6.14%5.98%5.92%6.3%7.71%10.4%8.61%
Gross Profit173.85M177.32M182.61M169.99M189.61M186.39M183.57M188.74M185.41M181.47M161.24M173.34M
Gross Margin %89.61%91.03%93.15%83.71%93.42%93.86%94.02%94.08%93.7%92.29%89.6%91.39%
Gross Profit Growth %-8.31%-4.87%-0.52%-9.93%2.26%2.71%13.85%8.89%10.83%8.83%-5.11%-0.24%
Operating Expenses159.84M154.64M167.99M142.28M166.23M168.21M163.16M168.86M178.03M199.76M199.57M155.03M
OpEx % of Revenue82.39%79.39%85.7%70.06%81.9%84.71%83.56%84.17%89.97%101.59%110.9%81.73%
Selling, General & Admin107.87M102.55M115.55M113.25M114.17M117.38M115.49M121.04M131.07M124.12M126.93M107.65M
SG&A % of Revenue55.6%52.65%58.94%55.77%56.25%59.11%59.15%60.34%66.24%63.12%70.53%56.75%
Research & Development30.18M28.94M31.01M29.93M31.14M31.74M30.14M30.85M31.02M32.03M39.61M31.29M
R&D % of Revenue15.55%14.86%15.82%14.74%15.34%15.98%15.44%15.38%15.67%16.29%22.01%16.49%
Other Operating Expenses1000K1000K1000K-901K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income14.01M22.68M14.62M27.71M23.38M18.18M20.41M19.88M7.38M-18.29M-38.33M18.31M
Operating Margin %7.22%11.65%7.46%13.65%11.52%9.15%10.45%9.91%3.73%-9.3%-21.3%9.65%
Operating Income Growth %-40.08%24.77%-28.36%39.4%216.76%199.41%153.24%8.58%-34.7%-1152.85%-143.94%552.38%
EBITDA35.8M45.83M36.05M47.44M44.29M37.28M37.94M36.84M23.32M25.32M-5.31M35.42M
EBITDA Margin %18.45%23.53%18.39%23.36%21.82%18.77%19.43%18.37%11.79%12.88%-2.95%18.67%
EBITDA Growth %-19.17%22.95%-4.98%28.76%89.91%47.22%815.08%4.02%-11.12%46.61%-201.31%281.99%
D&A (Non-Cash Add-back)21.79M23.15M21.43M19.73M20.91M19.1M17.54M16.96M15.94M43.61M33.02M17.11M
EBIT024.6M14.62M30.31M27.31M22.77M20.47M26.21M14.94M-9.81M-31.88M26.12M
Net Interest Income0-8.51M-8.52M-7.93M-6.71M-6.77M-7.56M-8.23M-7.09M-6.35M-6.07M-6.24M
Interest Income1.4M1.89M02.8M3.93M4.59M4.8M6.33M7.55M8.47M8.65M7.81M
Interest Expense-9.77M10.4M8.52M10.73M10.64M11.36M12.36M14.57M14.64M14.82M14.72M14.05M
Other Income/Expense-8.37M-8.49M-8.52M-8.13M-6.71M-6.77M-12.29M-8.23M-7.09M-6.35M-8.27M-6.24M
Pretax Income5.64M14.19M6.1M19.58M16.67M11.41M8.11M11.65M293K-24.64M-46.6M12.07M
Pretax Margin %2.91%7.29%3.11%9.64%8.21%5.75%4.15%5.81%0.15%-12.53%-25.9%6.36%
Income Tax-4.47M8.77M4.98M6.73M5.62M4.67M4.15M4.95M1.3M1.23M-8.11M-46.72M
Effective Tax Rate %-79.27%61.78%81.66%34.4%33.69%40.92%51.12%42.52%444.37%-5.01%17.39%-387.12%
Net Income10.11M5.42M1.12M12.84M11.05M6.74M12.26M6.69M-1.01M-25.87M-38.49M58.79M
Net Margin %5.21%2.79%0.57%6.32%5.45%3.39%6.28%3.34%-0.51%-13.16%-21.39%30.99%
Net Income Growth %-8.53%-19.51%-90.87%91.86%1195.34%126.05%131.85%-88.61%69.33%-1211.82%7.76%4254.49%
Net Income (Continuing)10.11M5.42M1.12M12.84M11.05M6.74M3.96M6.69M-1.01M-25.87M-38.49M58.79M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.030.020.000.040.030.020.030.02-0.00-0.06-0.090.14
EPS Growth %-1.33%-20.5%-89.87%80%-130.96%133.94%-85.71%--6.9%-
EPS (Basic)0.030.020.000.040.030.020.030.02-0.00-0.06-0.090.14
Diluted Shares Outstanding341.42M340.76M347.81M357.16M379.66M383.58M388.5M384.73M390.05M400.18M413.44M414.33M
Basic Shares Outstanding340.53M340.2M347.84M356.62M379.2M381.61M379.67M376.25M390.05M400.18M413.44M412.22M
Dividend Payout Ratio------------